ArticleMolecular biology reports2026
Osthole attenuates cartilage degradation and chondrocyte pyroptosis in knee osteoarthritis and is associated with activation of the PI3K/Akt pathway.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveTo verify the protective effect of osthole on knee osteoarthritis (KOA) and explore its mechanism of action.
methodsRats receiving the modified Hulth method and IL-1β-induced chondrocytes were used to construct in vivo and in vitro KOA models, respectively, and were subsequently treated by osthole. Hematoxylin-eosin and safranin O/fast green staining assays were used to assess the histological effects of osthole administered by oral gavage on the knee joint cartilage of KOA model rats. Western blotting, qRT-PCR, and immunofluorescence and immunohistochemical staining analyses were used to examine the expression of factors related to cartilage degeneration and chondrocyte pyroptosis in vitro and in vivo. The potential molecular targets of osthole action on KOA and their relevant pathways were predicted and verified.
resultsOsthole alleviated cartilage injury and lowered pathology scores in KOA rats. Osthole increased the levels of collagen Ⅱ but decreased those of ADAMTS-5, MMP3, and MMP13 in rat chondrocytes. Chondrocyte pyroptosis was alleviated by osthole, as evidenced by decreased levels of NLRP3, caspase-1, ASC, GSDMD, IL-1β, and IL-18 in rat chondrocytes and serum. Osthole prevented LDH release in rat chondrocytes induced by IL-1β. Bioinformatics analysis showed that osthole targets the PI3K/Akt pathway. PI3K inhibitor LY294002 treatment reversed the effects of osthole on chondrocyte degeneration and pyroptosis.
conclusionOsthole alleviated cartilage degradation and chondrocyte pyroptosis in KOA, and these effects were associated with activation of the PI3K/Akt signaling pathway.
Indexed as
Identifiers
42377751What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.